Clinical Trials Logo

Clinical Trial Summary

The primary aim of the study is the evaluation of the efficacy of remote ischemic preconditioning (RIPC) in terms of increase of the clearance of lactates 4 hours after the end of the hepatic resection. The secondary aims of the study are represented by the evaluation of the patients' postoperative recovery and the restoration of a normal lactate metabolism.


Clinical Trial Description

Hepatic surgery includes clamping of the hepatic peduncle (Pringle maneuver) to control intraoperative bleeding with a consequent reduction of postoperative complications. Surgical manipulations and Pringle maneuver, especially if prolonged and/or repeated, can cause ischemia-reperfusion damage. The technique of regional ischemic preconditioning was introduced to improve tolerance to ischemia. However, the scientific evidence currently does not support the routine use of regional ischemic preconditioning in hepatic surgery. It has recently been demonstrated that ischemic preconditioning can be effective when performed in the upper limb (RIPC). The main advantages of the remote ischaemic preconditiong compared to the regional one are the ease of use, the reduction of surgical time and hepatic ischemia. One of the most relevant epiphenomena of hepatic ischemia during hepatectomy is an increase in lactate levels in the immediate postoperative period that can be associated with an unfavorable outcome and can affect relevant clinical choices such as admission to intensive care. However, no previous studies have investigated the effectiveness of RIPC in improving lactate clearance after liver resection. The investigators hypothesized that applying RIPC before the start of the hepatic resection and the associated Pringle maneuvers could significantly increase lactate clearance 4 hours after the end of liver resection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05594641
Study type Interventional
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact Paola Aceto, MD
Phone 00390630154507
Email paola.aceto@policlinicogemelli.it
Status Recruiting
Phase N/A
Start date November 16, 2022
Completion date February 2024

See also
  Status Clinical Trial Phase
Completed NCT04092608 - Restrictive vs Goal Directed Fluid Therapy During Hepatobiliary Surgery N/A
Completed NCT02993640 - Optimization of Hepatic Hemodynamics During Liver Surgery Early Phase 1
Completed NCT05116735 - Biliary Fistula and Late Recurrence of Liver Hydatid Cyst: Role of Cysto-biliary Communication N/A
Recruiting NCT03686137 - Institut Paoli Calmettes Hepatic Surgery Database
Active, not recruiting NCT03270917 - ORANGE SEGMENTS: Open Versus Laparoscopic Parenchymal Preserving Postero-Superior Liver Segment Resection N/A
Completed NCT03793933 - ACS-NSQIP Calculator for Liver Surgery
Completed NCT01523353 - Prehabilitation in Liver Surgery Phase 1
Completed NCT00918619 - Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-Bound Fibrin Sealant During Liver Resection Phase 4
Completed NCT02050841 - Octaplas Pediatric Plasma Replacement Trial Phase 4
Recruiting NCT01267786 - The Effect of Volatile Anesthetics Sevoflurane and Desflurane on Liver, Renal and Cardiovascular Systems During Liver Surgery Phase 4
Completed NCT04668391 - Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament for Analgesia After Open Liver Surgery N/A
Recruiting NCT02715427 - Enhanced Recovery After Hepatic Surgery (MultiPAS). N/A